APGI Information Day, co-organized with EVONIK
ORAL SOLID DOSAGE FORMS - Formulation strategies and manufacturing approaches for challenging drugs
27 November, 2018
CNAM, 292 rue Saint-Martin, 75003 Paris, France
Download the program
More information and registration here !
In order to participate you only have to subscribe to APGI. Coffee breaks and lunch included.
SUBSCRIPTION TO APGI
Start your membership today and benefit from free technical workshops, significant discounts on scientific congresses and symposiums, and networking with individuals sharing the same passion about Pharmaceutical Technologies.
Yon can register online !
Formulation Days 2019
Advances in Formulation of Active Ingredients
January 10th and 11th, 2019, Lyon, France
Dear Madam, Dear Sir, We are pleased to announce that the Conference Formulation Days 2019 – “Advances in Formulation of Active Ingredients”, will be held on January 10th & 11th, 2019 in Lyon, France. It will be the first joint Conference of the International Society of Drug Delivery and Pharmaceutical Technology (APGI) and the Formulation Group of the French Chemical Society (SCF). The aim of this conference is to be a forum where experts from industry and academia working in the wide field of formulations dedicated to pharmaceutical or cosmetic applications can meet for cross-sector discussions. For this edition, the scientific program will cover four main topics:
- Materials, Biomaterials
- Formulations for cutaneous or mucosal administration
- Nanoparticles: nanomedicine, toxicology and regulation
- Process Engineering, characterization, modelling
For more details, please visit our website http://formulationdays2019.univ-lyon1.fr/
Call for abstracts Abstracts submissions are open until October 15th 2018.
Please see HERE for more information
Registration Early Bird Registration fees are available online until November 21st 2018 To register click HERE and follow the procedure.
3rd EUROPEAN CONFERENCE ON PHARMACEUTICS
25 to 26 March 2019 | Bologna, Italy
Short papier submission dealine 15 November 2018
|
We kindly would like to inform you of the date shift of our 3rd European Conference on Pharmaceutics in Bologna next year. Kindly The Bologna Children's Book Fair with more than 28 000 visitors and 1400 exhibitors changed the date to the same time as we already announced our conference. In order to avoid high trade fair prices for hotel and flights, we decided to change the date as well. You will find the reasons in the formal communication of Bologna Fair Group here. We are looking forward to meet you at the meeting in Bologna With the best regards, Your organising team of the European Conference on Pharmaceutics! |
Gold sponsor
The "APGI YOUNG INVESTIGATOR AWARD" (sponsored by Sanofi) recognizes the most outstanding doctoral thesis in the field of Pharmaceutical Technology each year.
If you defended your PhD thesis between 15 November 2017 and 14 November 2018, you can candidate for the 2018 "APGI YOUNG INVESTIGATOR AWARD".
Please send a pdf file of your thesis (in French or English) and a short curriculum vitae, by 24 November 2018, to APGI (apgi.asso@u-psud.fr) and Géraldine Piel (geraldine.piel@ulg.ac.be). The file can also be sent by We Transfer (a compressed version would be appreciated).
Thanks to the supervisors to forward this information to potentially interested current and former PhD students.
The price (accompanied by a check) will be officially awarded at the 3rd European Conference on Pharmaceutics, 25-26 March 2019 in Bologna, Italy
Best regards,
Geraldine Piel
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
Vienna, 2020
More information will follow closer to the meeting!
The Maurice-Marie JANOT award and lecture 2018 Sponsored by Sanofi
to be given to Professor Elias Fattal from the University of Paris Sud during the 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 19 March to 22 March 2018, Granada, Spain
Elias Fattal, is a full professor in Pharmaceutical Technology at the University of Par
is-Sud in Châtenay-Malabry in France and has been President of APGI from 2003 to 2010. He received his Pharmacy Degree and Ph.D. in Pharmaceutical Sciences from the University of Paris-Sud and followed a three year residency in hospital pharmacy at the University of Lille. After visiting the Department of Pharmaceutical Chemistry at the University of California, San Francisco for a post-doctoral position, he joined in 1992, the University of Paris-Sud as associate Professor and was appointed full Professor in 2000. He is heading the Institut Galien Paris-Sud a research unit associated to the CNRS. Dr Fattal research focuses on the design of nanotechnologies for targeted or local delivery of drugs and nucleic acids. He has authored more than 235 peer-reviewed articles and 28 book chapters and has issued 13 international patents (most of them granted in different countries). He has received the Pharmaceutical Sciences World Congress Research Achievement (2007), the controlled Release Society fellow Award (2016) and was awarded in 2016 by the French Academy of Sciences. He serves in the editorial board of 8 scientific journals.
More about the award
List of previous recipients
Catherine Tuleu appointed full professor
at the University College London School of Pharmacy
Catherine TULEU, PhD
Professor in Peadiatric Pharmaceutics
UCL School of Pharmacy
E-mail : c.tuleu@ucl.ac.uk
Catherine Tuleu (Reader, University College London School of Pharmacy) is a UK-qualified French pharmacist. Her first experience at UCL (The School of Pharmacy, University of London then and until 2012) was as a postdoc student, and then a research assistant in the Department of Pharmaceutics with Professor Michael Newton. After a stint as a lecturer at Kingston University, she returned to UCL in January 2003 as Pfizer Paediatric Drug Delivery Lecturer for the then newly established Centre for Paediatric Pharmacy Research. Catherine has traditionally been interested in gastrointestinal drug delivery, particularly colonic targeting, but since 2003 her main focus of research has been on drug delivery systems for neonates, infants and children. “ In the recent years, says Catherine, my research has focused on the most challenging paediatric subset: neonates – with a focus on those in low resource settings, as well as formulating for rare and neglected diseases.” She has been involved in various projects ranging from repurposing drugs, designing fast disintegrating tablets for a nipple shield to dose babies while breastfeeding, taste masking to exploring the rectal route for antimicrobial drug delivery, and gaining knowledge on the acceptability of flexible solid oral dosage forms, such as orodispersible films, dispersible tablets and multiparticulates. She has also been working on establishing methods to assess the taste of medicines in vitro, part of an emerging research field: sensory pharmaceuticsTM She was recently promoted and not only she joins the minority of female professors but she also becomes the first Professor of Paediatric Pharmaceutics.
